3B Blackbio DX Ltd | Industry : (Healthcare) | |
---|---|---|
BSE Code : 532067 |
NSE Symbol : - |
P/E(TTM) : 38.97 |
ISIN Demat : INE994E01018 |
Div & Yield% : 0.15 |
EPS(TTM) : 50.27 |
Book Value(₹) : 291.40 |
Market Cap(₹Cr) : 1,681.26 |
Face Value(₹) : 10.00 |
Particulars | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 |
---|---|---|---|---|---|---|
Gross Sales | 26.57 | 17.51 | 21.99 | 16.96 | 18.57 | 13.21 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 26.57 | 17.51 | 21.99 | 16.96 | 18.57 | 13.21 |
Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income | 3.43 | 3.68 | 4.15 | 2.47 | 2.75 | 2.96 |
Total Income | 30.00 | 21.18 | 26.13 | 19.42 | 21.31 | 16.17 |
Total Expenditure | 11.48 | 7.17 | 11.83 | 7.36 | 9.90 | 6.52 |
PBIDT | 18.52 | 14.02 | 14.30 | 12.06 | 11.41 | 9.65 |
Interest | 0.03 | 0.01 | 0.04 | 0.02 | 0.04 | 0.02 |
PBDT | 18.49 | 14.01 | 14.26 | 12.04 | 11.37 | 9.63 |
Depreciation | 0.22 | 0.22 | 0.27 | 0.20 | 0.22 | 0.18 |
Tax | 4.13 | 3.06 | 3.55 | 2.64 | 2.67 | 1.98 |
Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | 0.00 | 0.00 | 1.39 | 0.00 | 0.00 | 0.00 |
Reported Profit After Tax | 14.14 | 10.73 | 9.06 | 9.21 | 8.48 | 7.47 |
Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Adjusted Profit After Extra-ordinary item | 14.14 | 10.73 | 9.06 | 9.21 | 8.48 | 7.47 |
EPS (Unit Curr.) | 16.51 | 12.53 | 10.57 | 10.75 | 9.90 | 8.72 |
EPS (Adj) (Unit Curr.) | 16.51 | 12.53 | 10.57 | 10.75 | 9.90 | 8.72 |
Calculated EPS (Unit Curr.) | 16.51 | 12.53 | 10.57 | 10.75 | 9.89 | 8.72 |
Calculated EPS (Adj) (Unit Curr.) | 16.51 | 12.53 | 10.57 | 10.75 | 9.89 | 8.72 |
Calculated EPS (Ann.) (Unit Curr.) | 66.04 | 50.10 | 42.28 | 43.00 | 39.58 | 34.88 |
Calculated EPS (Adj) (Ann.) (Unit Curr.) | 66.04 | 50.10 | 42.28 | 43.00 | 39.58 | 34.88 |
Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 | 8.57 |
Reserve & Surplus | 219.21 | 219.21 | 188.60 | 167.28 | 162.68 | 162.65 |
Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
PBIDTM(%) | 69.70 | 80.07 | 65.03 | 71.11 | 61.44 | 73.05 |
PBDTM(%) | 69.59 | 80.01 | 64.85 | 70.99 | 61.23 | 72.90 |
PATM(%) | 53.22 | 61.28 | 41.20 | 54.30 | 45.67 | 56.55 |